Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 22

Sort by

Sort Order Select

Meeting Abstracts

231-OR: Phase I Study Investigating the PD, PK, and Safety of AT247 in Comparison with Novorapid and Fiasp

THOMAS R. PIEBER, THOMAS AUGUSTIN, CHRISTOPH MAGNES, DAVID J. GERRING, JAN JEZEK, SARAH J. HOWELL, LEON ZAKRZEWSKI, FIONA J. LAWRENCE, EVA SVEHLIKOVA

Diabetes 2020;69(Supplement_1):231-OR

https://doi.org/10.2337/db20-231-OR

Published: 01 June 2020

View article titled, 231-OR: Phase I Study Investigating the PD, PK, and Safety of AT247 in Comparison with Novorapid and Fiasp

Meeting Abstracts

1021-P: HbA1c Levels and Rates of Hypoglycemia with Insulin Degludec U200 and Insulin Glargine U300 Stratified by Renal Function Subgroups: Post Hoc Analysis from the CONCLUDE Trial

THOMAS R. PIEBER, HARPREET S. BAJAJ, SIMON R. HELLER, TING JIA, KAMLESH KHUNTI, DAVID C. KLONOFF, STEEN LADELUND, LAWRENCE A. LEITER, MELISSA V. HANSEN, ATHENA PHILIS-TSIMIKAS

Diabetes 2020;69(Supplement_1):1021-P

https://doi.org/10.2337/db20-1021-P

Published: 01 June 2020

View article titled, 1021-P: HbA1c Levels and Rates of Hypoglycemia with Insulin Degludec U200 and Insulin Glargine U300 Stratified by Renal Function Subgroups: Post Hoc Analysis from the CONCLUDE Trial

Meeting Abstracts

983-P: Effect and Safety of Flexible Dose Adjustment with Oral Semaglutide vs. Sitagliptin in Type 2 Diabetes: PIONEER 7

JOHN B. BUSE, BRUCE W. BODE, YOUNG MIN CHO, ERIK CHRISTIANSEN, CHRISTIN L. HERTZ, ANN MERTENS, SIGNE O. WALLENSTEIN, THOMAS R. PIEBER, FOR THE PIONEER 7 INVESTIGATORS

Diabetes 2019;68(Supplement_1):983-P

https://doi.org/10.2337/db19-983-P

Published: 01 June 2019

View article titled, 983-P: Effect and Safety of Flexible Dose Adjustment with Oral Semaglutide vs. Sitagliptin in Type 2 Diabetes: PIONEER 7

Meeting Abstracts

952-P: Improving Glycemic Management of Patients with Type 2 Diabetes in Acute Geriatric Care by Using a Basal Insulin Algorithm Incorporated into a Workflow and Decision Support System

ANGELA LIBISELLER, KATHARINA M. LICHTENEGGER, JULIA KOPANZ, ANTONELLA DE CAMPO, TATJANA WIESINGER, LISA WEIDINGER, LISA LAUBREITER, WALTER SCHIPPINGER, THOMAS TRUSKALLER, BETTINA C. LACKNER, PETER BECK, BERNHARD HÖLL, THOMAS R. PIEBER

Diabetes 2019;68(Supplement_1):952-P

https://doi.org/10.2337/db19-952-P

Published: 01 June 2019

View article titled, 952-P: Improving Glycemic Management of Patients with Type 2 Diabetes in Acute Geriatric Care by Using a Basal Insulin Algorithm Incorporated into a Workflow and Decision Support System

Meeting Abstracts

951-P: A Clinical Decision Support System for Basal-Bolus Insulin Therapy Is Moving to Hospital Routine Care: Efficacy, Safety, and Usability Confirmed

KATHARINA M. LICHTENEGGER, FELIX ABERER, ALEXANDRU C. TUCA, KLAUS DONSA, BERNHARD HÖLL, LUKAS SCHAUPP, JOHANNES PLANK, PETER BECK, FRIEDRICH FRUHWALD, THOMAS R. PIEBER, JULIA K. MADER

Diabetes 2019;68(Supplement_1):951-P

https://doi.org/10.2337/db19-951-P

Published: 01 June 2019

View article titled, 951-P: A Clinical Decision Support System for Basal-Bolus Insulin Therapy Is Moving to Hospital Routine Care: Efficacy, Safety, and Usability Confirmed

Meeting Abstracts

115-LB: Optimal Sampling Duration of Hybrid Closed-Loop Therapy to Determine Long-Term Glycemic Control in Adults with Type 1 Diabetes

LALANTHA LEELARATHNA, HOOD THABIT, MALGORZATA E. WILINSKA, LIA BALLY, JULIA K. MADER, SABINE ARNOLDS, CARSTEN BENESCH, THOMAS R. PIEBER, VIRAL N. SHAH, ANDERS L. CARLSON, RICHARD M. BERGENSTAL, MARK EVANS, ROMAN HOVORKA, ON BEHALF OF AP@HOME AND APCAM11 CONSORTIA

Diabetes 2019;68(Supplement_1):115-LB

https://doi.org/10.2337/db19-115-LB

Published: 01 June 2019

View article titled, 115-LB: Optimal Sampling Duration of Hybrid Closed-Loop Therapy to Determine Long-Term Glycemic Control in Adults with Type 1 Diabetes

Meeting Abstracts

1039-P: Hybrid Closed-Loop in Adults with Type 1 Diabetes: Impact of Baseline A1c on Glucose Outcomes and Insulin Delivery

LALANTHA LEELARATHNA, HOOD THABIT, MALGORZATA E. WILINSKA, LIA BALLY, JULIA K. MADER, SABINE ARNOLDS, THOMAS R. PIEBER, VIRAL N. SHAH, ANDERS CARLSON, RICHARD M. BERGENSTAL, MARK EVANS, ROMAN HOVORKA

Diabetes 2019;68(Supplement_1):1039-P

https://doi.org/10.2337/db19-1039-P

Published: 01 June 2019

View article titled, 1039-P: Hybrid Closed-Loop in Adults with Type 1 Diabetes: Impact of Baseline A1c on Glucose Outcomes and Insulin Delivery

Meeting Abstracts

2377-PUB: Evaluation of Structure, Documentation, and Treatment Quality of a New Insulin Chart at Departments of Internal Medicine

JULIA KOPANZ, KATHARINA M. LICHTENEGGER, GERALD SENDLHOFER, BARBARA SEMLITSCH, REGINA RIEDL, THOMAS R. PIEBER, CHRISTA TAX, GERNOT BRUNNER, JOHANNES PLANK

Diabetes 2019;68(Supplement_1):2377-PUB

https://doi.org/10.2337/db19-2377-PUB

Published: 01 June 2019

View article titled, 2377-PUB: Evaluation of Structure, Documentation, and Treatment Quality of a New Insulin Chart at Departments of Internal Medicine

Meeting Abstracts

286-OR: Phase 3 Results for Dasiglucagon as a Fast and Effective Treatment for Severe Hypoglycemia

THOMAS R. PIEBER, ULRIKE HOEVELMANN, JULIE WILLARD, LEONA PLUM-MOERSCHEL, ULRIK MOURITZEN, RAMIN TEHRANCHI, RONNIE ARONSON

Diabetes 2019;68(Supplement_1):286-OR

https://doi.org/10.2337/db19-286-OR

Published: 01 June 2019

View article titled, 286-OR: Phase 3 Results for Dasiglucagon as a Fast and Effective Treatment for Severe Hypoglycemia

Meeting Abstracts

Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods

RAPHAEL RAINER, HESHAM ELSAYED, FELIX ABERER, PETER BECK, THOMAS R. PIEBER, KLAUS DONSA, JOHANNES PLANK, JULIA K. MADER

Diabetes 2018;67(Supplement_1):2280-PUB

https://doi.org/10.2337/db18-2280-PUB

Published: 01 July 2018

View article titled, Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods

Meeting Abstracts

Assessment of Fasting Glucagon Levels in Subjects with Diabetes and Healthy Controls Using ELISA and RIA

MARTINA BRUNNER, MAXIMILIAN HABERLANDER, EVA SVEHLIKOVA, KATHARINA EBERHARD, ELISABETH STACH, ROBERT LIPP, BARBARA M. OBERMAYER-PIETSCH, THOMAS R. PIEBER, HARALD SOURIJ

Diabetes 2018;67(Supplement_1):1941-P

https://doi.org/10.2337/db18-1941-P

Published: 01 July 2018

View article titled, Assessment of Fasting Glucagon Levels in Subjects with Diabetes and Healthy Controls Using ELISA and RIA

Meeting Abstracts

Assessment of Infusion Set Survival of the Newly Developed Lantern Catheter in Type 1 Diabetes by Glucose CLA Technique

AMRA AJSIC, MICHAEL C. KRASSER, RASMUS JULIUSSEN, PERNELLE K. SCHØNDORFF, MATTHIAS HESCHEL, TINA PÖTTLER, DANIELA SCHWARZENBACHER, THOMAS AUGUSTIN, THOMAS R. PIEBER, GERLIES TREIBER, JULIA K. MADER

Diabetes 2018;67(Supplement_1):89-LB

https://doi.org/10.2337/db18-89-LB

Published: 01 July 2018

View article titled, Assessment of Infusion Set Survival of the Newly Developed Lantern Catheter in Type 1 Diabetes by Glucose CLA Technique

Meeting Abstracts

A Novel Composite Glucose Index (COGI) for Evaluating Closed-Loop Performance in Type 1 Diabetes

LALANTHA LEELARATHNA, HOOD THABIT, LIA BALLY, MALGORZATA E. WILINSKA, JULIA K. MADER, THOMAS R. PIEBER, MARK EVANS, ROMAN HOVORKA

Diabetes 2018;67(Supplement_1):926-P

https://doi.org/10.2337/db18-926-P

Published: 01 July 2018

View article titled, A Novel Composite Glucose Index (COGI) for Evaluating Closed-Loop Performance in Type 1 Diabetes

Meeting Abstracts

Chronic Kidney Disease (CKD) and Risk of Mortality, Cardiovascular (CV) Events, and Severe Hypoglycemia in Type 2 Diabetes (T2D)-DEVOTE Results

ASLAM AMOD, SCOTT S. EMERSON, STEVEN P. MARSO, DARREN K. MCGUIRE, THOMAS R. PIEBER, RODICA POP-BUSUI, RICHARD E. PRATLEY, BERNARD ZINMAN, MELISSA V. HANSEN, TING JIA, THOMAS MARK, NEIL R. POULTER, ON BEHALF OF THE DEVOTE STUDY GROUP

Diabetes 2018;67(Supplement_1):530-P

https://doi.org/10.2337/db18-530-P

Published: 01 July 2018

View article titled, Chronic Kidney Disease (CKD) and Risk of Mortality, Cardiovascular (CV) Events, and Severe Hypoglycemia in Type 2 Diabetes (T2D)-DEVOTE Results

Meeting Abstracts

Rates of Major Adverse Cardiovascular (CV) Events (MACE) and Mortality with Basal Insulin by Liraglutide Use—A DEVOTE Subanalysis

KIRSTINE BROWN-FRANDSEN, SCOTT S. EMERSON, STEVEN P. MARSO, DARREN K. MCGUIRE, THOMAS R. PIEBER, NEIL R. POULTER, BERNARD ZINMAN, RANDI GRØN, MARTIN LANGE, ALAN C. MOSES, PETRA ÖRSY, MATTIS F. RANTHE, RICHARD E. PRATLEY, ON BEHALF OF THE DEVOTE STUDY GROUP

Diabetes 2018;67(Supplement_1):1065-P

https://doi.org/10.2337/db18-1065-P

Published: 01 July 2018

View article titled, Rates of Major Adverse Cardiovascular (CV) Events (MACE) and Mortality with Basal Insulin by Liraglutide Use—A DEVOTE Subanalysis

Meeting Abstracts

Low-Dose IL-2 Signaling Is Specifically Impaired in Regulatory T Cells from T1D Patients

BARBARA PRIETL, SELINA KOFLER, STEFANIE STANZER, BARBARA M. OBERMAYER-PIETSCH, THOMAS R. PIEBER, HARALD SOURIJ

Diabetes 2018;67(Supplement_1):101-OR

https://doi.org/10.2337/db18-101-OR

Published: 01 July 2018

View article titled, Low-Dose IL-2 Signaling Is Specifically Impaired in Regulatory T Cells from T1D Patients

Meeting Abstracts

Cardiovascular (CV) Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (=65 Years) with Type 2 Diabetes (T2D)—Observations from DEVOTE

RICHARD E. PRATLEY, SCOTT S. EMERSON, EDWARD FRANEK, MATTHEW P. GILBERT, STEVEN P. MARSO, DARREN K. MCGUIRE, THOMAS R. PIEBER, NEIL R. POULTER, CHARLOTTE T. HANSEN, MELISSA V. HANSEN, THOMAS MARK, ALAN C. MOSES, BERNARD ZINMAN, ON BEHALF OF THE DEVOTE STUDY GROUP

Diabetes 2018;67(Supplement_1):108-OR

https://doi.org/10.2337/db18-108-OR

Published: 01 July 2018

View article titled, Cardiovascular (CV) Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (=65 Years) with Type 2 Diabetes (T2D)—Observations from DEVOTE

Meeting Abstracts

Glucose Metabolism after Overnight and Prolonged Fasting in Healthy Subjects

NORBERT J. TRIPOLT, SLAVEN STEKOVIC, JASMIN URL, FELIX ABERER, PETER N. PFERSCHY, REGINA RIEDL, BARBARA M. OBERMAYER-PIETSCH, THOMAS R. PIEBER, FRANK MADEO, HARALD SOURIJ

Diabetes 2018;67(Supplement_1):1821-P

https://doi.org/10.2337/db18-1821-P

Published: 01 July 2018

View article titled, Glucose Metabolism after Overnight and Prolonged Fasting in Healthy Subjects

Meeting Abstracts

Looking Beyond HbA1c—Evaluating Glycaemic Control during Closed-Loop Use in Type 1 Diabetes

HOOD THABIT, LALANTHA LEELARATHNA, MALGORZATA E. WILINSKA, CARSTEN BENESCH, SABINE ARNOLDS, JULIA K. MADER, THOMAS R. PIEBER, MARK EVANS, ROMAN HOVORKA

Diabetes 2018;67(Supplement_1):973-P

https://doi.org/10.2337/db18-973-P

Published: 01 July 2018

View article titled, Looking Beyond HbA1c—Evaluating Glycaemic Control during Closed-Loop Use in Type 1 Diabetes

Meeting Abstracts

Pharmacokinetic and Pharmacodynamic Properties of a Novel "Superfast" Insulin Aspart Formulation

THOMAS R. PIEBER, SARAH J. HOWELL, JAN JEZEK, DAVID J. GERRING

Diabetes 2018;67(Supplement_1):95-LB

https://doi.org/10.2337/db18-95-LB

Published: 01 July 2018

View article titled, Pharmacokinetic and Pharmacodynamic Properties of a Novel "Superfast" Insulin Aspart Formulation

NARROW

231-OR: Phase I Study Investigating the PD, PK, and Safety of AT247 in Comparison with Novorapid and Fiasp

1021-P: HbA1c Levels and Rates of Hypoglycemia with Insulin Degludec U200 and Insulin Glargine U300 Stratified by Renal Function Subgroups: Post Hoc Analysis from the CONCLUDE Trial

983-P: Effect and Safety of Flexible Dose Adjustment with Oral Semaglutide vs. Sitagliptin in Type 2 Diabetes: PIONEER 7

952-P: Improving Glycemic Management of Patients with Type 2 Diabetes in Acute Geriatric Care by Using a Basal Insulin Algorithm Incorporated into a Workflow and Decision Support System

951-P: A Clinical Decision Support System for Basal-Bolus Insulin Therapy Is Moving to Hospital Routine Care: Efficacy, Safety, and Usability Confirmed

115-LB: Optimal Sampling Duration of Hybrid Closed-Loop Therapy to Determine Long-Term Glycemic Control in Adults with Type 1 Diabetes

1039-P: Hybrid Closed-Loop in Adults with Type 1 Diabetes: Impact of Baseline A1c on Glucose Outcomes and Insulin Delivery

2377-PUB: Evaluation of Structure, Documentation, and Treatment Quality of a New Insulin Chart at Departments of Internal Medicine

286-OR: Phase 3 Results for Dasiglucagon as a Fast and Effective Treatment for Severe Hypoglycemia

Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods

Assessment of Fasting Glucagon Levels in Subjects with Diabetes and Healthy Controls Using ELISA and RIA

Assessment of Infusion Set Survival of the Newly Developed Lantern Catheter in Type 1 Diabetes by Glucose CLA Technique

A Novel Composite Glucose Index (COGI) for Evaluating Closed-Loop Performance in Type 1 Diabetes

Chronic Kidney Disease (CKD) and Risk of Mortality, Cardiovascular (CV) Events, and Severe Hypoglycemia in Type 2 Diabetes (T2D)-DEVOTE Results

Rates of Major Adverse Cardiovascular (CV) Events (MACE) and Mortality with Basal Insulin by Liraglutide Use—A DEVOTE Subanalysis

Low-Dose IL-2 Signaling Is Specifically Impaired in Regulatory T Cells from T1D Patients

Cardiovascular (CV) Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (=65 Years) with Type 2 Diabetes (T2D)—Observations from DEVOTE

Glucose Metabolism after Overnight and Prolonged Fasting in Healthy Subjects

Looking Beyond HbA1c—Evaluating Glycaemic Control during Closed-Loop Use in Type 1 Diabetes

Pharmacokinetic and Pharmacodynamic Properties of a Novel "Superfast" Insulin Aspart Formulation

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only